Compare KLA Corp. (KLAC) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
KLA Corp. vs Smith & Nephew plc — how do they compare? KLA Corp. trades at $216.62 (market cap $271.18B), while Smith & Nephew plc trades at $30.45 (market cap $12.64B). The key difference: KLA Corp. is far larger — about 21.5× Smith & Nephew plc's market cap, and Smith & Nephew plc pays the higher dividend (2.57%). Which is the better fit depends on your goals.
| KLAC | SNN | |
|---|---|---|
Market Cap | $271.18B | $12.64B |
Sector | Technology | Health |
52-Week High | $301.71 | $38.70 |
52-Week Low | $84.39 | $28.73 |
Enterprise Value | $272.37B | $15.41B |
Dividend Yield | 0.44% | 2.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About KLA Corp.
KLA designs and manufactures yield-management and process-monitoring diagnostic and control systems for the semiconductor manufacturing industry. The systems are used to analyze the manufacturing process at various steps in a semiconductor's development. The firm's laser-scanning products are used for wafer qualification, process monitoring, and equipment monitoring. KLA also provides inspection tools and systems for optical metrology and e-beam metrology.
Read more on KLAC →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
